Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1207 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1416 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1571 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1600 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1686 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1783 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1957 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 1966 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2056 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2133 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2189 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2242 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2448 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2465 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2484 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2524 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2526 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2571 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2755 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2757 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2820 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 2934 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3147 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3416 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3500 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3593 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3595 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3775 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 3803 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 4345 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 4504 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 5244 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 5691 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6014 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6249 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6283 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6466 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6601 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 6649 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 7203 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 7270 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 7999 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 8506 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 9046 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 9688 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 9779 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 12227 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 12450 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 14821 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 15694 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 16082 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 16171 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 21311 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 21870 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | 26628 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CHOLINE (CAS# 62-49-7); M+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |